Deep Dive: Rising Vitamin K Refusals and Infant Bleeding Risk — Background, What Changed, Viewpoints, and What to Watch

Deep Dive — 6 November 2026

A new study in JAMA Pediatrics (published November 5) documents a sharp rise in parents refusing the routine newborn vitamin K injection, with clear links to higher rates of potentially life-threatening bleeding in infants. This deep dive covers the background, what changed, competing viewpoints, and what to watch next.

Background

Newborns are born with low vitamin K stores. Without supplementation, they face a risk of vitamin K deficiency bleeding (VKDB), which can occur in the first days of life (early/classic) or between 2 weeks and 6 months (late-onset). Late VKDB often involves intracranial hemorrhage and can cause permanent disability or death. Since the 1960s, a single intramuscular injection of vitamin K at birth has been standard in the United States and has reduced VKDB to rare levels when administered.

Oral vitamin K regimens exist but require multiple doses and are less reliable for preventing late-onset bleeding, according to the American Academy of Pediatrics and CDC.

What changed

Researchers at Children’s Hospital of Philadelphia analyzed records from more than 5.2 million U.S. births between 2017 and 2025. The percentage of infants without documented vitamin K administration rose from 3.1% in 2017 to 6.8% in 2025. A separate Truveta analysis of more than 1 million births showed the refusal rate accelerating further in the first half of 2026.

Infants who did not receive the injection experienced:

The absolute numbers remain relatively small, but the relative increase tracks the rise in non-receipt. The study does not establish causation for every case, but the association is consistent with decades of prior evidence on VKDB prevention.

Competing viewpoints

Public-health and pediatric consensus: AAP, CDC, and most neonatologists continue to recommend the intramuscular shot as the most effective single intervention. They note that VKDB is largely preventable and that oral alternatives leave gaps, especially for late-onset disease. Rising refusals are viewed as part of broader skepticism toward newborn interventions and vaccines.

Parent-choice and natural-health perspectives: Some parents cite concerns about synthetic vitamin K, injection pain, or a desire to minimize medical interventions at birth. Online communities sometimes promote oral vitamin K drops or dietary approaches, or question the necessity given modern diets. A subset frames the shot as part of a larger pattern of routine procedures they prefer to decline.

Evidence to date has not shown equivalent protection from single-dose oral regimens for late VKDB. Hospitals and state health departments generally still follow AAP guidance.

What to watch next

Parents expecting a baby should raise the topic with their obstetric and pediatric teams before delivery so the decision is informed rather than made under time pressure. The injection remains one of the lowest-risk, highest-impact preventive steps available in the newborn period.

Sources: JAMA Pediatrics (November 5, 2026); Children’s Hospital of Philadelphia; Reuters; Washington Post; CDC and AAP guidance on vitamin K.